Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer

Bart Degrève; Graciela Andreï; Manuel Izquierdo; J Piette; Kevin W. Morin; EE Knaus; LI Wiebe; I Basrah; RT Walker; De Clercq Erik; Jan Balzarini

doi:10.1038/sj.gt.3300502

Back

Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer

Article 1997 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Interaction of the bicyclic nucleoside analogues (BCNAs) with human varicella-zoster virus (VZV) and simian varicella virus (SVV) thymidine kinase and VZV DNA polymerase

Rebecca Sienaert, Lieve Naesens, G Luoni, Michael W. Wathen, Wayne L. Gray, Graciela Andreï, Robert Snoeck, De Clercq Erik, Christopher McGuigan, Jan Balzarini

Article2003

Characterization of varicella-zoster virus (VZV) mutants resistant to bicyclic pyrimidine nucleoside analogues (BCNAs)

Graciela Andreï, Ghislain Opdenakker, Jan Balzarini, De Clercq Erik, Christopher McGuigan, Robert Snoeck

Article2002

Susceptibilities of several drug-resistant varicella-zoster virus (VZV) strains to bicyclic pyrimidine nucleoside analogues (BCNAs)

Graciela Andreï, Rebecca Sienaert, Lieve Naesens, De Clercq Erik, Christopher McGuigan, Jan Balzarini, Robert Snoeck

Article1986

Characterization of a varicella-zoster virus variant with altered thymidine kinase activity

Shirô Shigeta, S Mori, Tomoyuki Yokota, K Konno, De Clercq Erik

Article2003

Highly Potent and Selective Inhibition of Varicella—Zoster Virus Replication by Bicyclic Furo[2,3‐d]pyrimidine Nucleoside Analogues

De Clercq Erik